In the most recent trading session, Medpace (MEDP) closed at $561.65, indicating a -1.27% shift from the previous trading day.

Abacus FCF Advisors LLC lifted its holdings in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 23.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,663 shares of the company's stock after buying an additional 3,917 shares

Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG) or Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?

Medpace (NASDAQ: MEDP - Get Free Report) and SBC Medical Group (NASDAQ: SBC - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Profitability This table compares Medpace and SBC Medical

In the latest trading session, Medpace (MEDP) closed at $568.36, marking a +1.45% move from the previous day.

Investors interested in stocks from the Medical Services sector have probably already heard of BrightSpring Health Services, Inc. (BTSG) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?

Fisher Asset Management LLC lessened its stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 29.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 125,347 shares of the company's stock after selling 53,245 shares during the quarter. Fisher Asset Management LLC

Stock News Prada acquires Versace: Prada Group (HKG:1913) completed a €1.25 billion deal to buy Versace from Capri Holdings (CPRI), bringing the brand under t

Medpace Holdings, Inc. (NASDAQ: MEDP - Get Free Report) CEO August Troendle sold 6,830 shares of Medpace stock in a transaction dated Thursday, November 20th. The stock was sold at an average price of $598.49, for a total value of $4,087,686.70. Following the completion of the sale, the chief executive officer directly owned 855,485 shares in

Clarkston Capital Partners LLC purchased a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 129,259 shares of the company's stock, valued at approximately $40,569,000. Clarkston Capital Partners LLC owned approximately 0.46% of Medpace